The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

REFERENCES

1Rolader R, Daugherty LN, Liu Y, Feldman RJ. Prevalence and predictors of pruritus in pemphigus compared with bullous pemphigoid: a cross-sectional study. J Am Acad Dermatol. 2020; 83: 251–254.
10.1016/j.jaad.2020.01.025
PubMed Web of Science® Google Scholar
2Hajdu K, Brodszky V, Stalmeier PFM, Ruzsa G, Tamasi B, Gulacsi L, et al. Patient-assigned health utility values for controlled and uncontrolled pemphigus vulgaris and foliaceus. J Eur Acad Dermatol Venereol. 2019; 33: 2106–2113.
10.1111/jdv.15765
CAS PubMed Web of Science® Google Scholar
3Raap U, Limberg MM, Kridin K, Ludwig RJ. Pruritus is associated with an increased risk for the diagnosis of autoimmune skin blistering diseases: a propensity-matched global study. Biomol Ther. 2023; 13: 13.
Google Scholar
4Blauvelt A, Teixeira HD, Simpson EL, Costanzo A, De Bruin-Weller M, Barbarot S, et al. Efficacy and safety of Upadacitinib vs Dupilumab in adults with moderate-to-severe atopic dermatitis: a randomized clinical trial. JAMA Dermatol. 2021; 157: 1047–1055.
10.1001/jamadermatol.2021.3023
PubMed Web of Science® Google Scholar
5Ferreira S, Guttman-Yassky E, Torres T. Selective JAK1 inhibitors for the treatment of atopic dermatitis: focus on Upadacitinib and Abrocitinib. Am J Clin Dermatol. 2020; 21: 783–798.
10.1007/s40257-020-00548-6
PubMed Web of Science® Google Scholar
6Guénin SS, Lebwohl MG. Oral JakInhibitor, Upadacitinib use in treatment of pemphigus foliaceus. SKIN Journal of Cutaneous Medicine. 2023; 7: 881–885.
10.25251/skin.7.4.5
Google Scholar
7Holstein J, Solimani F, Baum C, Meier K, Pollmann R, Didona D, et al. Immunophenotyping in pemphigus reveals a T(H)17/T(FH)17 cell-dominated immune response promoting desmoglein1/3-specific autoantibody production. J Allergy Clin Immunol. 2021; 147: 2358–2369.
10.1016/j.jaci.2020.11.008
CAS PubMed Web of Science® Google Scholar
8Suyama K, Sakai D, Watanabe M. The role of IL-17-mediated inflammatory processes in the pathogenesis of intervertebral disc degeneration and herniation: a comprehensive review. Front Cell Dev Biol. 2022; 10:857164.
10.3389/fcell.2022.857164
PubMed Web of Science® Google Scholar
9Lotti R, Shu E, Petrachi T, Marconi A, Palazzo E, Quadri M, et al. Soluble Fas ligand is essential for blister formation in pemphigus. Front Immunol. 2018; 9: 370.
10.3389/fimmu.2018.00370
PubMed Web of Science® Google Scholar

Volume39, Issue3

March 2025

Pages e222-e224

Pemphigus foliaceus successfully treated with upadacitinib

Open Research

DATA AVAILABILITY STATEMENT

REFERENCES

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Pemphigus foliaceus successfully treated with upadacitinib

Open Research

DATA AVAILABILITY STATEMENT

REFERENCES

References

Related

Information